Immuno Cure and PharmaJet Announce Collaboration to Advance a Novel HIV Therapeutic DNA Vaccine Using Needle-Free Technology in Humans

2025-06-19 – Press Releases – www.prnewswire.com

HONG KONG, June 19, 2025 /PRNewswire/ — Immuno Cure BioTech (“Immuno Cure”), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce its upcoming collaboration with PharmaJet® to evaluate the safety and immunogenicity of HIV therapeutic DNA vaccine,…

Read the full article here.